Profil
Glen C.
MacDonald is currently the President, CEO, CFO & Director at Leucadia Finance Partners, Inc. He was previously the Chief Scientific Officer at Viventia Biotech, Inc. from 2005 to 2012 and again from 2012 to 2016.
He was also the Chief Scientific Officer at Sesen Bio, Inc. from 2016 to 2017.
Additionally, he held a position as Principal at Princess Margaret Hospital Foundation and The University of North Carolina at Charlotte.
Dr. MacDonald received his undergraduate degree from the University of Guelph in 1980, his graduate degree from the University of Manitoba in 1987, and his doctorate from the University of Manitoba in 1993.
Aktiva positioner av Glen MacDonald
| Företag | Position | Start |
|---|---|---|
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Verkställande Direktör | - |
Tidigare kända positioner av Glen MacDonald
| Företag | Position | Slut |
|---|---|---|
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2016-09-01 |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Teknisk/Vetenskaplig/F&U Direktör | 2012-01-01 |
| CARISMA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Princess Margaret Hospital Foundation | Företagsledare/Principal | - |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Glen MacDonalds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princess Margaret Hospital Foundation | |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Health Technology |
















